Health-related quality of life in postmastectomy lymphedema patients

Effect of complete decongestive therapy and home program on health-related quality of life in post mastectomy lymphedema patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN13242080

Enrollment

Registered

2016-04-07

Start date

2013-07-01

Completion date

Unknown

Last updated

2017-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmastectomy lymphedema Cancer

Interventions

Sixty participants were divided into two groups: conventional treatment (CT) group and complete decongestive therapy (CDT) group. A systematic random sampling procedure was used to include the partic

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Females aged between 50 and 70 years 2. Unilateral mastectomy for stage I and II breast cancer 3. Completed radiotherapy and chemotherapy sessions 4. Developed lymphedema more than 3cm compared to contralateral extremity

Exclusion criteria

Exclusion criteria: 1. Primary lymphedema 2. Bilateral lymphedema 3. Pulmonary edema 4. Congestive heart failure 5. Contraindications limiting therapy

Design outcomes

Primary

Measure	Time frame
1. Pain measured using the visual analogue score (VAS) at baseline, 4th week and 6th week 2. Health-related Quality of Life, evaluated with the EORTC QLQ C30 and EORTC QLQ-BR23 questionnaires Measurements were taken at baseline, 4 and 6 weeks.	—

Secondary

Measure	Time frame
Quality of life measured using European Organization of Research and Treatment for Cancer quality of life questionnaire (EORTC QLQ-C30) and the EORTC QLQ-BR23 breast cancer-specific questionnaire. Measured at baseline, 4th week and 6th week.	—

Countries

India

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 1, 2026